DHI
52
-4
UHS
62
6
GM
65
-7
PLD
56
-5
PHM
65
-5
BBY
42
2
ROK
64
-2
PSA
63
2
KLAC
53
-3
ETR
72
3
CVS
52
-6
BXP
60
5
MLM
58
-2
AKAM
50
-3
DG
6
-4
AAL
51
-3
MOS
43
-5
EMC
56
-3
TSN
42
3
PSX
50
3
DHI
52
-4
UHS
62
6
GM
65
-7
PLD
56
-5
PHM
65
-5
BBY
42
2
ROK
64
-2
PSA
63
2
KLAC
53
-3
ETR
72
3
CVS
52
-6
BXP
60
5
MLM
58
-2
AKAM
50
-3
DG
6
-4
AAL
51
-3
MOS
43
-5
EMC
56
-3
TSN
42
3
PSX
50
3
Financhill
Back

Charles River Laboratories International Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

CRL
Charles River Laboratories International

Last Price:
198.90
Seasonality Move:
9.91%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
135.25
Seasonality Move:
14.88%
Sell
45
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International a Buy, Sell or Hold?

  • The current Charles River Laboratories International [CRL] share price is $197.75. The Score for CRL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRL Stock Price Chart

What is Charles River Laboratories International's stock price today?

  • The Charles River Laboratories International share price today is $197.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 51.77 Buy
Chaikin Money Flow: 86440 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (181.52 - 206.66) Buy
Bollinger Bands (100): (187.24 - 217.22) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

CRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.28 Buy
20-day SMA: 196.51 Buy
50-day SMA: 194.94 Buy
200-day SMA: 218.91 Sell
8-day EMA: 196.22 Buy
20-day EMA: 195.88 Buy
50-day EMA: 196.47 Buy
200-day EMA: 208.13 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Charles River Laboratories International Earnings Growth & CRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $0.14 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Charles River Laboratories International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):